Rakuten TV Launches its AVOD Service in Europe
15.10.2019 11:30:00 EEST | Business Wire | Press release
Rakuten TV, one of the leading video-on-demand platforms in Europe, today announced the launch of its first AVOD - ad-supported video-on-demand - channels within the platform. This new business model will allow viewers to watch a wide range of content for free.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191015005048/en/
Rakuten TV's new UI 4.0 including "Free" section (Photo: Rakuten TV)
The free section of Rakuten TV will launch with an initial offer including Hollywood and local content to be expanded to additionally include exclusive Rakuten content, TV series, documentary series, news and sport channels in the coming months - with a combined linear and on-demand offer.
Among the exclusive content, Rakuten TV will present on its AVOD channel Matchday - Inside FC Barcelona, the new documentary series about FC Barcelona from the inside, offering previously unseen and exclusive scenes from the players’ private lives. Narrated by John Malkovich, Matchday – Inside FC Barcelona is a creation of Barça Studios, FC Barcelona’s own production house, in collaboration with Kosmos Studios, Rakuten, Inc. in association with Rakuten H Collective Studio and Producciones del Barrio.
Expanding its business model proposition, Rakuten TV will be the first to combine TVOD and AVOD products across Europe, meeting the changing needs of viewers. The free ad-supported channels will enrich the original proposition of Rakuten TV - Your Cinema at Home - offering Smart TV viewers the best cinematic experience with the latest new releases in the best audiovisual quality. Thanks to the presence of a remote control button providing direct access to the app on major Smart TVs, Rakuten TV content will be just a click away for over 30 million households across Europe.
In a time when the streaming industry is increasingly changing and exploring avenues such as AVOD, Rakuten TV is proud to pioneer this trend in Europe as the main VOD platform combining different business models - TVOD, AVOD and SVOD - which are oriented around meeting all audience needs.
Jacinto Roca, Rakuten TV Founder and CEO, stated: “We are incredibly proud to take this step after having tripled our presence in Europe just a few months ago. Rakuten TV continues to evolve rapidly alongside consumer trends within the industry, where there is a clear trend of advertisers moving away from linear TV and towards VOD. This is a unique opportunity for Rakuten TV which has already direct access to millions of European households through its branded remote control button of the main Smart TV brands. This is the mere beginning of a huge project which will see the launch of additional channels and exclusive content in the coming months”.
The service will be available in beta version, across the complete 2019 SMART TV line up, and will be progressively rolled out in other platforms including mobile and desktop.
Advertising sales will be managed by Rakuten Marketing, a subsidiary of Rakuten Inc. Nick Stamos, Rakuten Marketing CEO, stated: “Advertisers and agencies are eager to be among the first to showcase their brands in this exclusive and groundbreaking advertising platform. As VOD is emerging as a powerful media channel, our clients have been anticipating this launch from RakutenTV, so we are very excited to bring this new proposition to market across Europe.”
Rakuten Viber, Rakuten’s instant messaging service, will also be involved in the project, leveraging its community of 2 million Barça fans to promote Matchday.
Nielsen will be the data partner (DMP-data management platform) used to target advertisements at a digital level
This news comes alongside a renewed platform design for Rakuten TV, with a more attractive look & feel, a more intuitive user interface and a simpler user journey. Within the new interface, viewers will discover the new channel offering featuring ad-supported content inside the ‘free’ section implemented within the header menu.
The announcement took place during the conference “AVOD on the Rise” at MIPCOM 2019, where Founder and CEO of Rakuten TV, Jacinto Roca, spoke about the AVOD industry and its evolution with other top players in the entertainment field.
Rakuten TV
Rakuten TV is one of the leading Video On-Demand platforms in Europe. It offers a TVOD service (Transactional VOD) providing viewers a true cinematic experience with the latest new releases in the best audiovisual quality. It also includes an AVOD (Advertising VOD) section, Rakuten TV Free, in a blend of thematic channels embracing Hollywood classics, local, exclusive and themed content, all for free.
Rakuten TV is available in 42 countries and forms part of Rakuten, Inc., one of the world’s leading internet services companies, offering a wide variety of services for consumers and businesses, with a focus on e-commerce, fintech and digital content. Rakuten, headquartered in Japan, is also known for its partnerships with FC Barcelona, the NBA, the Golden State Warriors, Davis Cup and Spartan Race.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191015005048/en/
Contact information
Media Contacts:
For further information please contact:
Premier PR – Rakuten TV
Charlie Wainwright - Premier PR on behalf of Rakuten TV
charlie.wainwright@premiercomms.com
0207 292 7372
Rakuten TV
Fabiana Cumia – Communication Director – fabiana.cumia@rakuten.com
Iraia Arza – PR & Communication Specialist – iraia.arza@rakuten.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom